The QuikClot Control+™ Hemostatic Device is now indicated for temporary control of external and identifiable sites of internal mild, moderate, severe, and life-threatening bleeding in the United ...

Teleflex (NYSE: TFX) + announced today that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device. The expanded indications now include all grades of ...

Baxter launches the Hemopatch Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing. Baxter International Inc. (NYSE: BAX), a renowned leader in pioneering surgical ...

If your baby is healthy, skip the "What to Do" section. Go directly to the topic that relates to your question for advice. Many newborn rashes that have no clear cause are heat rashes. Heat rashes are ...